发明公开
EP1708712A1 TREATMENT OF MALIGNANT GLIOMAS WITH TGF-BETA INHIBITORS 审中-公开
治疗恶性胶质瘤TGF-β抑制剂

  • 专利标题: TREATMENT OF MALIGNANT GLIOMAS WITH TGF-BETA INHIBITORS
  • 专利标题(中): 治疗恶性胶质瘤TGF-β抑制剂
  • 申请号: EP04815564.2
    申请日: 2004-12-22
  • 公开(公告)号: EP1708712A1
    公开(公告)日: 2006-10-11
  • 发明人: WELLER, Michael
  • 申请人: Scios, Inc.
  • 申请人地址: 6500 Paseo Padre Parkway Fremont, CA 94555 US
  • 专利权人: Scios, Inc.
  • 当前专利权人: Scios, Inc.
  • 当前专利权人地址: 6500 Paseo Padre Parkway Fremont, CA 94555 US
  • 代理机构: Fisher, Adrian John
  • 优先权: US532346P 20031224
  • 国际公布: WO2005065691 20050721
  • 主分类号: A61K31/517
  • IPC分类号: A61K31/517 A61K31/53 A61K31/505 A61P35/00
TREATMENT OF MALIGNANT GLIOMAS WITH TGF-BETA INHIBITORS
摘要:
The invention concerns methods of treating malignant gliomas, by administering inhibitors of TGF-β the TGF-β signaling pathway, including molecules preferably binding to the type I TGF-β receptor (TGFβ-R1). Preferably, the inhibitors are non-peptide small molecules, including quinazoline derivatives. The invention also concerns methods for reversing the TGF-β-mediated effect on glioma cells to make them less refractile to signaling and other immune cells, comprising contacting a glioma cell or tissue in vivo or in vitro, with an inhibitor of TGF-β.
信息查询
0/0